Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes☆

Abele-Horn, 1996, A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients, Infection, 6, 426, 10.1007/BF01713042 Abi-Said, 1997, The epidemiology of hematogenous candidiasis caused by different Candida species, Clin Infect Dis, 24, 1122, 10.1086/513663 Anaissie, 1991, Trichosporonosis—meeting the challenge, Eur J Clin Microbiol Infect Dis, 9, 711, 10.1007/BF01972495 Beck Sague, 1993, Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Surveillance System, J Infect Dis, 167, 1247, 10.1093/infdis/167.5.1247 Bow, 1997, Documented fungal infections after chemotherapy for acute leukemia, Clin Infect Dis, 24, 394 Bow, 1995, Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia; The pathogenetic role of the antileukemic regimen, Clin Infect Dis, 21, 361, 10.1093/clinids/21.2.361 Demitrovicova, 1997, Bacteremia and fungaemia after antineoplastic chemotherapy—association between cytotoxics and particular pathogerus, Anti-infect Drugs Chemother, 3, 26 Edwards, 1992, Should all patients with candidemia be treated with antifungal agents?, Clin Infect Dis, 15, 422, 10.1093/clind/15.3.422 Ellis, 1994, Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematologic malignancies, Eur J Clin Microbiol Infect Dis, 1, 3, 10.1007/BF02026116 Foltan, V. (1999). Consumption of Antibiotics in Slovakia in 1997–1998 (in Slovak). State Institute of Drug control. Bratislava, p. 25. Fraser, 1992, Candidemia in a tertiary care hospital, Clin Infect Dis, 15, 414, 10.1093/clind/15.3.414 Goldman, 1993, Candida krusei fungaemia, Medicine, 3, 143, 10.1097/00005792-199305000-00002 Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301 Guiot, 1994, Risk factors for fungal infections in patients with malignant hematological disorders, Clin Infect Dis, 18, 525, 10.1093/clinids/18.4.525 Harvey, 1987, Nosocomial fungaemia in a large community teaching hospital, Arch Intern Med, 147, 2117, 10.1001/archinte.1987.00370120053011 Horn, 1985, Fungaemia in a cancer hospital changing frequency, earlier onset, and results of therapy, Rev Infect Dis, 7, 645, 10.1093/clinids/7.5.646 Huttova, 1998, Candida fungaemia in neonates, Pediatr Infect Dis J, 17, 1112 Karabinis, 1988, Risk factors for candidemia in cancer patients, J Clin Microbiol, 33, 1467 Kim-Stamos, 1995, Candidaemia in a paediatric population, Clin Infect Dis, 20, 571, 10.1093/clinids/20.3.571 Knaus, 1985, APACHE II, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009 Komshian, 1989, Fungaemia caused by Candida species and Torulopsis glabrata in the hospitalized patient, Rev Infect Dis, 11, 379, 10.1093/clinids/11.3.379 Kunova, 1995, Candida glabrata, Candida krusei, non-albicans Candida spp. and other fungal organisms in a sixty bed National Cancer Center in 1989–1993, Chemotherapy, 41, 39, 10.1159/000239322 Lecciones, 1992, Vascular catheterassociated fungemia in patients with cancer, Clin Infect Dis, 14, 875, 10.1093/clinids/14.4.875 McQuillen, 1992, Invasive infections due to C. krusei, Clin Infect Dis, 14, 472, 10.1093/clinids/14.2.472 Nguyen, 1995, Therapeutic approach in patients with candidemia, Arch Intern Med, 11, 2429, 10.1001/archinte.1995.00430220087009 Pfaller, 1998, National surveillance of nosocomial blood stream infections due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program, Diagn Microbiol Infect Dis, 31, 327, 10.1016/S0732-8893(97)00240-X Pfaller, 1998, National surveillance of nosocomial blood stream infections due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program, Diagn Microbiol Infect Dis, 30, 121, 10.1016/S0732-8893(97)00192-2 Pfaller, 1998, National epidemiology of mycoses survey, Diagn Microbiol Infect Dis, 31, 289, 10.1016/S0732-8893(97)00245-9 Pfaller, 1999, Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States, Diagn Microbiol Infect Dis, 33, 217, 10.1016/S0732-8893(98)00160-6 Rex, 1994, A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia, N Engl J Med, 331, 1325, 10.1056/NEJM199411173312001 Rex, 1995, Resistance of Candida species to fluconazole, Antimicrob Agents Chemother, 39, 1, 10.1128/AAC.39.1.1 Sandven, 1998, Constant low rate of fungaemia in Norway, 1991 to 1996, J Clin Microbiol, 36, 3455, 10.1128/JCM.36.12.3455-3459.1998 Van’t Wout, 1996, Fluconazole in treatment of Candida infections caused by non-albicans species, Eur J Clin Microbiol Infect Dis, 15, 362 Verweij, 1994, Amphotericin B versus amphotericin B plus 5-flucytosine, Infection, 22, 81, 10.1007/BF01739009 Viscoli, 1999, Candidemia in cancer patients, Clin Infect Dis, 28, 1071, 10.1086/514731 Voss, 1996, Occurrence of yeasts bloodstream infections between 1987 and 1995 in five Dutch university hospitals, Eur J Clin Microbiol Infect Dis, 15, 909, 10.1007/BF01690507 Voss, 1997, Candidemia in intensive care unit patients, Infection, 25, 8, 10.1007/BF02113499 Walsh, 1996, Fungaemia in HIV-positive children, Clin Infect Dis, 20, 732 Wenzel, 1995, Nosocomial candidemia, Clin Infect Dis, 20, 1531, 10.1093/clinids/20.6.1531 Wey, 1988, Hospital-acquired candidemia. The attributable mortality and excess length of stay, Arch Intern Med, 148, 2642, 10.1001/archinte.1988.00380120094019 White, 1997, Epidemiology of invasive candidiasis, Int J Infect Dis, 51, 7 Wingard, 1995, Importance of Candida species other than C. albicans, Antimicrob Agents Chemother, 12, 133